| JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | BIOTECNOLOGÍA | 60,701124 | 15/11/2024 | -4,51% | -37,14% | * |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | BIOTECNOLOGÍA | 65,780000 | 15/11/2024 | -2,58% | -33,95% | * |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 61,150000 | 15/11/2024 | -6,97% | -40,75% | * |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 86,840000 | 15/11/2024 | -6,89% | -40,62% | * |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | BIOTECNOLOGÍA | 66,729661 | 15/11/2024 | -3,17% | -34,11% | * |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) EUR | MIXTO AGRESIVO GLOBAL | 122,680000 | 15/11/2024 | 10,05% | 6,86% | **** |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) USD | MIXTO AGRESIVO GLOBAL | 122,006992 | 15/11/2024 | 9,31% | 6,38% | **** |
| JPM TOTAL EMERGING MARKETS INCOME A (DIST) EUR | MIXTO AGRESIVO GLOBAL | 90,890000 | 15/11/2024 | 6,58% | -3,04% | ** |
| JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | MIXTO AGRESIVO GLOBAL | 95,290000 | 15/11/2024 | 4,15% | -9,44% | * |
| JPM TOTAL EMERGING MARKETS INCOME C (ACC) EUR | MIXTO AGRESIVO GLOBAL | 137,930000 | 15/11/2024 | 10,78% | 9,28% | **** |
